Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
BMC Pharmacology & Toxicology
|
June 27, 2013
Quantitation of small intestinal permeability during normal human drug absorption
David G Levitt
BMC Clinical Pharmacology
|
March 28, 2003
The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption
David G Levitt
BMC Clinical Pharmacology
|
August 17, 2002
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
David G Levitt
BMC Medical Education
|
November 17, 2010
Careers of an elite cohort of U.S. basic life science postdoctoral fellows and the influence of their mentor's citation record
David G Levitt
Clinical and Experimental Gastroenterology
|
September 13, 2014
Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease
David G Levitt, Michael D Levitt
Clinical and Experimental Gastroenterology
|
December 25, 2023
Development of a Pharmacokinetic Model That Accounts for the Plasma Concentrations of Conjugated and Unconjugated Bilirubin Observed in a Variety of Disease States
David G Levitt, Michael D Levitt
BMC Gastroenterology
|
March 29, 2012
Quantitative modeling of the physiology of ascites in portal hypertension
David G Levitt, Michael D Levitt
ADMET & DMPK
|
February 13, 2023
Development and application of a simple pharmacokinetic model that quantitatively describes the distribution and elimination of the commonly measured proteins
David G Levitt, Michael D Levitt
International Journal of General Medicine
|
August 4, 2016
Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements
David G Levitt, Michael D Levitt
Clinical and Experimental Gastroenterology
|
August 2, 2017
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states
David G Levitt, Michael D Levitt
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
BMC Pharmacology & Toxicology
|
June 27, 2013
Quantitation of small intestinal permeability during normal human drug absorption
David G Levitt
BMC Clinical Pharmacology
|
March 28, 2003
The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption
David G Levitt
BMC Clinical Pharmacology
|
August 17, 2002
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
David G Levitt
BMC Medical Education
|
November 17, 2010
Careers of an elite cohort of U.S. basic life science postdoctoral fellows and the influence of their mentor's citation record
David G Levitt
Clinical and Experimental Gastroenterology
|
September 13, 2014
Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease
David G Levitt, Michael D Levitt
Clinical and Experimental Gastroenterology
|
December 25, 2023
Development of a Pharmacokinetic Model That Accounts for the Plasma Concentrations of Conjugated and Unconjugated Bilirubin Observed in a Variety of Disease States
David G Levitt, Michael D Levitt
BMC Gastroenterology
|
March 29, 2012
Quantitative modeling of the physiology of ascites in portal hypertension
David G Levitt, Michael D Levitt
ADMET & DMPK
|
February 13, 2023
Development and application of a simple pharmacokinetic model that quantitatively describes the distribution and elimination of the commonly measured proteins
David G Levitt, Michael D Levitt
International Journal of General Medicine
|
August 4, 2016
Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements
David G Levitt, Michael D Levitt
Clinical and Experimental Gastroenterology
|
August 2, 2017
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states
David G Levitt, Michael D Levitt
Page
of 4